BeOne Medicines (BEIGF) EBIT Margin Growth (1y) (2016 - 2026)
BeOne Medicines (BEIGF) EBIT Margin Growth (1y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
821,726.73 Bn |
821,726.69 Bn |
- |
- |
| 2 |
Belite Bio |
57,768.00 Bn |
57,768.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
16,655.88 Bn |
16,655.88 Bn |
- |
- |
| 4 |
Legend Biotech |
3,540.00 Bn |
3,539.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,526.26 Bn |
1,526.24 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,520.09 Bn |
1,520.09 Bn |
- |
- |
| 7 |
Psyence Biomedical |
223.87 Bn |
223.87 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.47 Bn |
107.23 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.22 Bn |
91.22 Bn |
- |
- |
| 10 |
BeOne Medicines |
- |
- |
1.35 Bn |
1,552.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
1,552.00 |
| Dec 31, 2025 |
1,939.00 |
| Sep 30, 2025 |
2,356.00 |
| Jun 30, 2025 |
1,821.00 |
| Mar 31, 2025 |
3,576.00 |
| Dec 31, 2024 |
5,345.00 |
| Sep 30, 2024 |
514.00 |
| Jun 30, 2024 |
4,201.00 |
| Mar 31, 2024 |
4,814.00 |
| Dec 31, 2023 |
6,279.00 |
| Sep 30, 2023 |
9,594.00 |
| Jun 30, 2023 |
7,510.00 |
| Mar 31, 2023 |
6,166.00 |
| Dec 31, 2022 |
-21,235.00 |
| Sep 30, 2022 |
11,086.00 |
| Jun 30, 2022 |
18,794.00 |
| Mar 31, 2022 |
-15,615.00 |
| Dec 31, 2021 |
57,348.00 |
| Sep 30, 2021 |
25,929.00 |
| Jun 30, 2021 |
23,020.00 |
